首页> 外文会议>ACS Symposium on Chemistry and Safety of Acrylamide in Food >ACRYLAMIDE NEUROTOXICITY: NEUROLOGICAL, MORHOLOGICAL AND MOLECULAR ENDPOINTS IN ANIMAL MODELS
【24h】

ACRYLAMIDE NEUROTOXICITY: NEUROLOGICAL, MORHOLOGICAL AND MOLECULAR ENDPOINTS IN ANIMAL MODELS

机译:丙烯酰胺神经毒性:动物模型中神经,病理学和分子终点

获取原文

摘要

Acrylamide (AA) monomer is used in numerous chemical industries and is a contaminant in potato- and grain-based foods prepared at high temperatures. Although experimental animal studies have implicated carcinogenicity and reproductive toxicity as possible consequences of exposure, neurotoxicity is the only outcome identified by epidemiological studies of occupationally exposed human populations. Neurotoxicity in both humans and laboratory animals is characterized by ataxia and distal skeletal muscle weakness. Early neuropathological studies suggested that AA neurotoxicity was mediated by distal axon degeneration. However, more recent electrophysiological and quantitative morphometric analyses have identified nerve terminals as primary sites of AA action. A resulting defect in neurotransmitter release appears to be the pathophysiological basis of the developing neurotoxicity. Corresponding mechanistic research suggests that AA impairs release by adducting cysteine residues on functionally important presynaptic proteins. In this publication we provide an overview of recent advances in AA research. This includes a discussion of the cumulative nature of AA neurotoxicity and the putative sites and molecular mechanisms of action.
机译:丙烯酰胺(AA)单体用于许多化学工业,是在高温下制备的马铃薯和谷物食品中的污染物。虽然实验动物的研究已经牵连致癌性和生殖毒性暴露的可能后果,神经毒性是通过职业接触人群的流​​行病学研究中确定的唯一的结局。人类和实验室动物的神经毒性的特征在于共济失调和远端骨骼肌弱点。早期神经病理学研究表明,AA神经毒性是通过远端轴突变性介导的。然而,最近的电生理和定量形态学分析已经将神经末端鉴定为AA作用的主要位点。导致神经递质释放中的缺陷似乎是发展神经毒性的病理生理学基础。相应的机制研究表明,AA通过在功能重要的突触前蛋白上加入半胱氨酸残基来损害。在本出版物中,我们概述了AA研究的最新进展。这包括讨论AA神经毒性的累积性质和推定部位和分子作用机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号